[1] Yang B, Liu X, Peng C, et al. Silicosis: from pathogenesis to therapeutics[J]. Front Pharmacol, 2025, 16: 1516200. doi:10.3389/fphar.2025.1516200. [2] Leung CC, Yu IT, Chen W. Silicosis[J]. Lancet, 2012, 379: 2008-2018. [3] 毛翎, 彭莉君, 王焕强, 等. 尘肺病治疗中国专家共识(2024年版)[J]. 环境与职业医学, 2024, 41: 1-21. [4] Liu TT, Sun HF, Han YX, et al. The role of inflamma-tion in silicosis[J]. Front Pharmacol, 2024, 15: 1362509. doi:10.3389/fphar.2024.1362509. [5] Yuan H, He Y, Zhang Y, et al. Crystalline silica-induced endoplasmic reticulum stress promotes the pathogenesis of silicosis by augmenting proinflammatory interstitial pulmonary macrophages[J]. Sci Total Environ, 2024, 946: 174299. doi:10.1016/j.scitotenv.2024.174299. [6] 彭方达, 代静, 丁春光. 巨噬细胞极化在矽肺纤维化中的研究进展[J]. 中华劳动卫生职业病杂志, 2024, 42: 315-320. [7] Zhang H, Liu Y, Liu J, et al. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment[J]. J Hematol Oncol, 2024, 17: 5. doi:10.1186/s13045-024-01524-x. [8] Serezani CH, Ballinger MN, Aronoff DM, et al. Cyclic AMP: master regulator of innate immune cell function[J]. Am J Respir Cell Mol Biol, 2008, 39: 127-132. [9] Liu Y, Zhang J, Hu Y, et al. BI 1015550 improves silica-induced silicosis and LPS-induced acute lung injury in mice[J]. Molecules, 2025, 30: 1311. doi:10.3390/molecules30061311. [10] 丁咏伟, 耿玉聪, 刘燕, 等. 环磷酸腺苷信号对矽肺纤维化形成的影响[J]. 中国现代医学杂志, 2017, 27: 1-5. [11] Liu Y, Xu H, Geng Y, et al. Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentia-tion via PKA/CREB/CBP signaling in rats with silicosis[J]. Respir Res, 2017, 18: 38. doi:10.1186/s12931-017-0523-z. [12] Xia Y, Zhou F, Hui H, et al. ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target[J]. J Transl Med, 2024, 22: 1114. doi:10.1186/s12967-024-05869-2. [13] Bauman KA, Wettlaufer SH, Okunishi K, et al. The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice[J]. J Clin Invest, 2010, 120: 1950-1960. [14] Roberts MJ, May LT, Keen AC, et al. Inhibition of the proliferation of human lung fibroblasts by prostacyclin receptor agonists is linked to a sustained cAMP signal in the nucleus[J]. Front Pharmacol, 2021, 12: 669227. doi:10.3389/fphar.2021.669227. [15] Zmajkovicova K, Menyhart K, Bauer Y, et al. The antifibrotic activity of prostacyclin receptor agonism is mediated through inhibition of YAP/TAZ[J]. Am J Respir Cell Mol Biol, 2019, 60: 578-591. |